MobiHealth News May 24, 2022
The company develops a breakthrough device for detecting residual cancer tissues.
Perth-based medical device firm OncoRes Medical has bagged $12.5 million in funding to support its upcoming clinical trials.
It recently scored $9.5 million in a Series A2 funding co-led by VC Brandon Capital and Future of Healthcare Fund by Australian Unity. A separate $3 million funding was secured from the Round 12 grant of the Cooperative Research Centres Projects of AusIndustry, the business programme arm of Australia’s Department of Industry, Science, Energy and Resources.
WHY IT MATTERS
OncoRes has developed its own oncology imaging system called quantitative micro-elastography (QME). It overlays optical coherence tomography, which measures the intensity of back-scattered light, to micro-elastography, which measures the stiffness of tissues...
Today's Sponsors
Today's Sponsor